Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Hemophilia Gene Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Hemophilia A 1.4.3 Hemophilia B 1.5 Market by Application 1.5.1 Global Hemophilia Gene Therapy Market Share by Application: 2020 VS 2026 1.5.2 Hemophilia A Gene Therapy 1.5.3 Hemophilia B Gene Therapy 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Hemophilia Gene Therapy Market Perspective (2015-2026) 2.2 Hemophilia Gene Therapy Growth Trends by Regions 2.2.1 Hemophilia Gene Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Hemophilia Gene Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Hemophilia Gene Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Hemophilia Gene Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key Hemophilia Gene Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Hemophilia Gene Therapy Players by Market Size 3.1.1 Global Top Hemophilia Gene Therapy Players by Revenue (2015-2020) 3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Hemophilia Gene Therapy Market Concentration Ratio 3.2.1 Global Hemophilia Gene Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Hemophilia Gene Therapy Revenue in 2019 3.3 Hemophilia Gene Therapy Key Players Head office and Area Served 3.4 Key Players Hemophilia Gene Therapy Product Solution and Service 3.5 Date of Enter into Hemophilia Gene Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Hemophilia Gene Therapy Historic Market Size by Type (2015-2020) 4.2 Global Hemophilia Gene Therapy Forecasted Market Size by Type (2021-2026) 5 Hemophilia Gene Therapy Breakdown Data by Application (2015-2026) 5.1 Global Hemophilia Gene Therapy Market Size by Application (2015-2020) 5.2 Global Hemophilia Gene Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Hemophilia Gene Therapy Market Size (2015-2020) 6.2 Hemophilia Gene Therapy Key Players in North America (2019-2020) 6.3 North America Hemophilia Gene Therapy Market Size by Type (2015-2020) 6.4 North America Hemophilia Gene Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Hemophilia Gene Therapy Market Size (2015-2020) 7.2 Hemophilia Gene Therapy Key Players in Europe (2019-2020) 7.3 Europe Hemophilia Gene Therapy Market Size by Type (2015-2020) 7.4 Europe Hemophilia Gene Therapy Market Size by Application (2015-2020) 8 China 8.1 China Hemophilia Gene Therapy Market Size (2015-2020) 8.2 Hemophilia Gene Therapy Key Players in China (2019-2020) 8.3 China Hemophilia Gene Therapy Market Size by Type (2015-2020) 8.4 China Hemophilia Gene Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan Hemophilia Gene Therapy Market Size (2015-2020) 9.2 Hemophilia Gene Therapy Key Players in Japan (2019-2020) 9.3 Japan Hemophilia Gene Therapy Market Size by Type (2015-2020) 9.4 Japan Hemophilia Gene Therapy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Hemophilia Gene Therapy Market Size (2015-2020) 10.2 Hemophilia Gene Therapy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Hemophilia Gene Therapy Market Size by Type (2015-2020) 10.4 Southeast Asia Hemophilia Gene Therapy Market Size by Application (2015-2020) 11 India 11.1 India Hemophilia Gene Therapy Market Size (2015-2020) 11.2 Hemophilia Gene Therapy Key Players in India (2019-2020) 11.3 India Hemophilia Gene Therapy Market Size by Type (2015-2020) 11.4 India Hemophilia Gene Therapy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Hemophilia Gene Therapy Market Size (2015-2020) 12.2 Hemophilia Gene Therapy Key Players in Central & South America (2019-2020) 12.3 Central & South America Hemophilia Gene Therapy Market Size by Type (2015-2020) 12.4 Central & South America Hemophilia Gene Therapy Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Spark Therapeutics 13.1.1 Spark Therapeutics Company Details 13.1.2 Spark Therapeutics Business Overview and Its Total Revenue 13.1.3 Spark Therapeutics Hemophilia Gene Therapy Introduction 13.1.4 Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020)) 13.1.5 Spark Therapeutics Recent Development 13.2 Ultragenyx 13.2.1 Ultragenyx Company Details 13.2.2 Ultragenyx Business Overview and Its Total Revenue 13.2.3 Ultragenyx Hemophilia Gene Therapy Introduction 13.2.4 Ultragenyx Revenue in Hemophilia Gene Therapy Business (2015-2020) 13.2.5 Ultragenyx Recent Development 13.3 Shire PLC 13.3.1 Shire PLC Company Details 13.3.2 Shire PLC Business Overview and Its Total Revenue 13.3.3 Shire PLC Hemophilia Gene Therapy Introduction 13.3.4 Shire PLC Revenue in Hemophilia Gene Therapy Business (2015-2020) 13.3.5 Shire PLC Recent Development 13.4 Sangamo Therapeutics 13.4.1 Sangamo Therapeutics Company Details 13.4.2 Sangamo Therapeutics Business Overview and Its Total Revenue 13.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Introduction 13.4.4 Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020) 13.4.5 Sangamo Therapeutics Recent Development 13.5 Bioverativ 13.5.1 Bioverativ Company Details 13.5.2 Bioverativ Business Overview and Its Total Revenue 13.5.3 Bioverativ Hemophilia Gene Therapy Introduction 13.5.4 Bioverativ Revenue in Hemophilia Gene Therapy Business (2015-2020) 13.5.5 Bioverativ Recent Development 13.6 BioMarin 13.6.1 BioMarin Company Details 13.6.2 BioMarin Business Overview and Its Total Revenue 13.6.3 BioMarin Hemophilia Gene Therapy Introduction 13.6.4 BioMarin Revenue in Hemophilia Gene Therapy Business (2015-2020) 13.6.5 BioMarin Recent Development 13.7 uniQure 13.7.1 uniQure Company Details 13.7.2 uniQure Business Overview and Its Total Revenue 13.7.3 uniQure Hemophilia Gene Therapy Introduction 13.7.4 uniQure Revenue in Hemophilia Gene Therapy Business (2015-2020) 13.7.5 uniQure Recent Development 13.8 Freeline Therapeutics 13.8.1 Freeline Therapeutics Company Details 13.8.2 Freeline Therapeutics Business Overview and Its Total Revenue 13.8.3 Freeline Therapeutics Hemophilia Gene Therapy Introduction 13.8.4 Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020) 13.8.5 Freeline Therapeutics Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Hemophilia Gene Therapy Key Market Segments Table 2. Key Players Covered: Ranking by Hemophilia Gene Therapy Revenue Table 3. Ranking of Global Top Hemophilia Gene Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Hemophilia A Table 6. Key Players of Hemophilia B Table 7. Global Hemophilia Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Hemophilia Gene Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Hemophilia Gene Therapy Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Hemophilia Gene Therapy Market Share by Regions (2015-2020) Table 11. Global Hemophilia Gene Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Hemophilia Gene Therapy Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Hemophilia Gene Therapy Market Growth Strategy Table 17. Main Points Interviewed from Key Hemophilia Gene Therapy Players Table 18. Global Hemophilia Gene Therapy Revenue by Players (2015-2020) (Million US$) Table 19. Global Hemophilia Gene Therapy Market Share by Players (2015-2020) Table 20. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Gene Therapy as of 2019) Table 21. Global Hemophilia Gene Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Hemophilia Gene Therapy Product Solution and Service Table 24. Date of Enter into Hemophilia Gene Therapy Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$) Table 27. Global Hemophilia Gene Therapy Market Size Share by Type (2015-2020) Table 28. Global Hemophilia Gene Therapy Revenue Market Share by Type (2021-2026) Table 29. Global Hemophilia Gene Therapy Market Size Share by Application (2015-2020) Table 30. Global Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$) Table 31. Global Hemophilia Gene Therapy Market Size Share by Application (2021-2026) Table 32. North America Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$) Table 33. North America Key Players Hemophilia Gene Therapy Market Share (2019-2020) Table 34. North America Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$) Table 35. North America Hemophilia Gene Therapy Market Share by Type (2015-2020) Table 36. North America Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$) Table 37. North America Hemophilia Gene Therapy Market Share by Application (2015-2020) Table 38. Europe Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Hemophilia Gene Therapy Market Share (2019-2020) Table 40. Europe Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$) Table 41. Europe Hemophilia Gene Therapy Market Share by Type (2015-2020) Table 42. Europe Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$) Table 43. Europe Hemophilia Gene Therapy Market Share by Application (2015-2020) Table 44. China Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$) Table 45. China Key Players Hemophilia Gene Therapy Market Share (2019-2020) Table 46. China Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$) Table 47. China Hemophilia Gene Therapy Market Share by Type (2015-2020) Table 48. China Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$) Table 49. China Hemophilia Gene Therapy Market Share by Application (2015-2020) Table 50. Japan Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Hemophilia Gene Therapy Market Share (2019-2020) Table 52. Japan Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$) Table 53. Japan Hemophilia Gene Therapy Market Share by Type (2015-2020) Table 54. Japan Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$) Table 55. Japan Hemophilia Gene Therapy Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Hemophilia Gene Therapy Market Share (2019-2020) Table 58. Southeast Asia Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Hemophilia Gene Therapy Market Share by Type (2015-2020) Table 60. Southeast Asia Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Hemophilia Gene Therapy Market Share by Application (2015-2020) Table 62. India Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$) Table 63. India Key Players Hemophilia Gene Therapy Market Share (2019-2020) Table 64. India Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$) Table 65. India Hemophilia Gene Therapy Market Share by Type (2015-2020) Table 66. India Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$) Table 67. India Hemophilia Gene Therapy Market Share by Application (2015-2020) Table 68. Central & South America Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Hemophilia Gene Therapy Market Share (2019-2020) Table 70. Central & South America Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Hemophilia Gene Therapy Market Share by Type (2015-2020) Table 72. Central & South America Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Hemophilia Gene Therapy Market Share by Application (2015-2020) Table 74. Spark Therapeutics Company Details Table 75. Spark Therapeutics Business Overview Table 76. Spark Therapeutics Product Table 77. Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$) Table 78. Spark Therapeutics Recent Development Table 79. Ultragenyx Company Details Table 80. Ultragenyx Business Overview Table 81. Ultragenyx Product Table 82. Ultragenyx Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$) Table 83. Ultragenyx Recent Development Table 84. Shire PLC Company Details Table 85. Shire PLC Business Overview Table 86. Shire PLC Product Table 87. Shire PLC Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$) Table 88. Shire PLC Recent Development Table 89. Sangamo Therapeutics Company Details Table 90. Sangamo Therapeutics Business Overview Table 91. Sangamo Therapeutics Product Table 92. Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$) Table 93. Sangamo Therapeutics Recent Development Table 94. Bioverativ Company Details Table 95. Bioverativ Business Overview Table 96. Bioverativ Product Table 97. Bioverativ Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$) Table 98. Bioverativ Recent Development Table 99. BioMarin Company Details Table 100. BioMarin Business Overview Table 101. BioMarin Product Table 102. BioMarin Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$) Table 103. BioMarin Recent Development Table 104. uniQure Company Details Table 105. uniQure Business Overview Table 106. uniQure Product Table 107. uniQure Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$) Table 108. uniQure Recent Development Table 109. Freeline Therapeutics Business Overview Table 110. Freeline Therapeutics Product Table 111. Freeline Therapeutics Company Details Table 112. Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$) Table 113. Freeline Therapeutics Recent Development Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemophilia Gene Therapy Market Share by Type: 2020 VS 2026 Figure 2. Hemophilia A Features Figure 3. Hemophilia B Features Figure 4. Global Hemophilia Gene Therapy Market Share by Application: 2020 VS 2026 Figure 5. Hemophilia A Gene Therapy Case Studies Figure 6. Hemophilia B Gene Therapy Case Studies Figure 7. Hemophilia Gene Therapy Report Years Considered Figure 8. Global Hemophilia Gene Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 9. Global Hemophilia Gene Therapy Market Share by Regions: 2020 VS 2026 Figure 10. Global Hemophilia Gene Therapy Market Share by Regions (2021-2026) Figure 11. Porter's Five Forces Analysis Figure 12. Global Hemophilia Gene Therapy Market Share by Players in 2019 Figure 13. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Gene Therapy as of 2019 Figure 14. The Top 10 and 5 Players Market Share by Hemophilia Gene Therapy Revenue in 2019 Figure 15. North America Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 16. Europe Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 17. China Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Japan Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Southeast Asia Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. India Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Central & South America Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Spark Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. Spark Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020) Figure 24. Ultragenyx Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Ultragenyx Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020) Figure 26. Shire PLC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Shire PLC Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020) Figure 28. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Sangamo Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020) Figure 30. Bioverativ Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Bioverativ Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020) Figure 32. BioMarin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. BioMarin Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020) Figure 34. uniQure Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. uniQure Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020) Figure 36. Freeline Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Freeline Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020) Figure 38. Bottom-up and Top-down Approaches for This Report Figure 39. Data Triangulation Figure 40. Key Executives Interviewed

Spark Therapeutics Ultragenyx Shire PLC Sangamo Therapeutics Bioverativ BioMarin uniQure Freeline Therapeutics